Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 50 citing articles:

Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Mingyao Huang, Quansong Ji, Huiyan Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review
Byeongsang Oh, Thomas Eade, Gillian Lamoury, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2353-2353
Open Access | Times Cited: 25
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
Paola Muscolino, Barbara Granata, Fausto Omero, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4875-4875
Open Access | Times Cited: 9
Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
Rachel M. Golonka, Matam Vijay‐Kumar
Advances in cancer research (2020), pp. 171-255
Closed Access | Times Cited: 22
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors.
Beibei Pei, Xiaoyan Ma, Na Wu, et al.
PubMed (2023) Vol. 35, Iss. 3, pp. 252-265
Closed Access | Times Cited: 7
The microbiome, gastrointestinal cancer, and immunotherapy
Rachel C. Newsome, Ye Yang, Christian Jobin
Journal of Gastroenterology and Hepatology (2021) Vol. 37, Iss. 2, pp. 263-272
Open Access | Times Cited: 17
Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
Ao Huang, Xin Zhang, Jian Zhou
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
Matthieu Delaye, Adrien Rousseau, Léah Mailly-Giacchetti, et al.
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108442-108442
Open Access | Times Cited: 6
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
Dario Spanu, Andrea Pretta, Eleonora Lai, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 7, pp. 1319-1332
Open Access | Times Cited: 9
The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
Liliana Montella, Federica Sarno, Annamaria Ambrosino, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1909-1909
Open Access | Times Cited: 11
Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle
Cecilia Hes, R. Thomas Jagoe
BJC Reports (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 4
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betül Gök Yavuz, Saumil Datar, Shadi Chamseddine, et al.
(2023)
Open Access | Times Cited: 4
The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma
Liqiu Kou, Xiaolu Xie, Xiu Chen, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3953-3969
Open Access | Times Cited: 4
Metformin facilitates anti-PD-L1 efficacy through the regulation of intestinal microbiota
Xiaopeng Zhao, Chuang Liu, Licheng Peng, et al.
Genes and Immunity (2023) Vol. 25, Iss. 1, pp. 7-13
Closed Access | Times Cited: 4
Faecalibacterium prausnitzii: one species with multiple potential implications in cancer research
Rodrigo de Oliveira Formiga, Harry Sokol
Gut (2024), pp. gutjnl-334338
Closed Access | Times Cited: 1
The crosstalk between intestinal bacterial microbiota and immune cells in colorectal cancer progression
Xiaozi Wen, Xufang Ye, Xuejun Yang, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 3, pp. 620-632
Closed Access | Times Cited: 5
Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
Jingxin Ma, Qi Wei, Xin Cheng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Disputes and Challenges of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Hongwei Yao, Wen G. Jiang, Zhi‐Chun Gu, et al.
Frontiers research topics (2024)
Open Access
Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival
Yaoxian Xiang, Chan Zhang, Jing Wang, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access
Effect of a novel food rich in miraculin on the intestinal microbiome of malnourished patients with cancer and dysgeusia
Julio Plaza‐Díaz, Marco Brandimonte-Hernández, Bricia López‐Plaza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article
Aun R. Shah, S. Mukherjee
Hepatoma Research (2024)
Open Access
Circulating Cell-Free Microbial DNA Signatures and Plasma Soluble CD14 Level Are Associated with Clinical Outcomes of Anti-PD-1 Therapy in Advanced Melanoma Patients
Bernadeta Pietrzak, Katarzyna Tomela, Łukasz Galus, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12982-12982
Open Access
Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
Yongbo Kang, Yue Cai
World Journal of Gastroenterology (2022) Vol. 28, Iss. 20, pp. 2248-2250
Open Access
Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment
Haiqiang Wang, Fan Shi, Shudan Zheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access
Previous Page - Page 2

Scroll to top